NCT03692897: An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection |
|
|
| Recruiting | N/A | 5000 | Canada, US | All approved therapies for the treatment of Chronic Hepatitis B (CHB) | Target PharmaSolutions, Inc. | Hepatitis B, Hepatitis, Liver Diseases | 01/26 | 01/26 | | |
NCT02815891: A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) |
|
|
| Recruiting | N/A | 15000 | Europe, US | | Target PharmaSolutions, Inc. | Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | 07/36 | 07/36 | | |
